期刊文献+

羟苯磺酸钙联合依那普利治疗早期老年2型糖尿病肾病的疗效观察 被引量:3

下载PDF
导出
摘要 选择在本院接受住院治疗的早期老年2型糖尿病肾病患者作为研究对象,随机分为单用依那普利治疗的对照组及接受羟苯磺酸钙联合依那普利治疗的观察组患者,比较两组患者的尿蛋白水平、血糖及肝肾功能、生活质量及负面情绪等差异。结果观察组患者治疗后的m Alb和α1-MG水平均明显低于对照组患者(P<0.05)。观察组患者接受羟苯磺酸钙联合依那普利治疗后的空腹血糖、餐后2h血糖、谷丙转氨酶、谷氨酰转移酶、尿素氮及肌酐水平均明显低于对照组患者(P<0.05)。观察组患者接受羟苯磺酸钙联合依那普利治疗后的生活质量评分明显高于对照组患者,抑郁及焦虑评分明显低于对照组患者(P<0.05)。结论羟苯磺酸钙联合依那普利治疗有助于改善患者肝肾功能,减少尿蛋白,缓解患者的负面情绪同时提高生活质量,具有积极的临床意义。
出处 《实用糖尿病杂志》 2015年第4期22-24,共3页 Journal of Practical Diabetology
  • 相关文献

参考文献8

  • 1李浪波,秦爱平,赵新兰,李文静,陈凯,唐卓.羟苯磺酸钙治疗早期老年2型糖尿病的肾病的疗效观察[J].中国临床药理学杂志,2013,29(12):900-902. 被引量:22
  • 2董静,梁翠格,张晓倩,李明龙,刘占峰,赵家军,于桂娜.羟苯磺酸钙治疗早期糖尿病肾病的疗效观察[J].山东大学学报(医学版),2008,46(1):80-83. 被引量:39
  • 3Leal EC, Martins J, Voabil P. Calcium dobesilate inhibits the alterations in tight junction proteins and leukocyte adhesion to retinal endothelial cells induced by diabetes. Diabetes 2010; 59 ( 10 ) : 2637- 2645.
  • 4Velpandian T,Nirmal J,Gupta P,et al. Evaluation of calcium dobesilate for its anti-cataract potential in experimental animal models. Methods Find Exp Clin Pharmacol 2010;32(3) : 171-179.
  • 5颜斌,谢巍,曹仁贤.替米沙坦联合依那普利对2型糖尿病早期肾病的临床观察[J].中南医学科学杂志,2011,39(5):529-530. 被引量:7
  • 6Javadzadeh A, Ghorbanihaghjo A, Adi FH, et al. Calcium do- besilate reduces endothelin-1 and high-sensitivity C-reactive protein se- rum levels in patients with diabetic retinopathy. Mol Vis 2013 ; 19 (7) : 62-68.
  • 7Alda O,Valero MS,Perebroom D,et al. In vitro effect of cal- cium dobesilate on oxidative/inflammatory stress in human varicose .veins. Phlebology 2011 ;26(8) : 332-337.
  • 8Haritoglou C, Gerss J, Sauerland C, et al. Effect of calcium do- besilate on occurrence of diabetic maeular oedema ( CALDIRET stud- y) : randomised, double-blind, placebo-controlled, multicentre trial. Lancet 2009;373(11) : 1364-1371.

二级参考文献21

  • 1于素清,陈月香,王波.洛丁新对不同时期糖尿病肾病患者血浆内皮素的影响[J].放射免疫学杂志,2004,17(3):207-208. 被引量:2
  • 2邹大进,陈月.糖尿病微血管并发症的发病机制及治疗[J].中华糖尿病杂志(1006-6187),2005,13(5):393-395. 被引量:41
  • 3王少波,施秉银,王养维,张新利.纤溶酶原激活物抑制物-1与糖尿病肾病关系的研究[J].广东药学院学报,2006,22(1):89-90. 被引量:3
  • 4Khan M A, Dashwood M R, Mumtaz F H, et al. Upregulation of endothelin A receptor sites in the rabbit kindney: Potential relevance to the early pathogenesis of diabetic nephropathy[ J]. Nephron, 1999, 83(3):261-267.
  • 5Itoh Y, Nakai A, Kakizawa H, et al. Alteration of endothelin- 1 concentration in STZ-induced diabetic rat nephropathy. Effects of a PGI(2) derivative[J]. Hormone Research, 2001, 56 (5-6) : 165-171.
  • 6Kasai N, Sugimoto K, Horiba N, et al. Effect of D-glucose on nitric oxide release from glomerular endothelial cell [ J ]. Diabetes Metab Res Rev, 2001, 17(3) :217-238.
  • 7Garay R P, Hannaert P, Chiavaroli C. Calcium dobesilate in the treatment of diabetic retinopathy [ J ]. Treat Endocrinol, 2005, 4(4) :221-232.
  • 8Parving H H, Osterby R, Ritz E. Diabetic nephropathy. In: Brenner BM, Levine S, Eds. The Kidney[M]. 6th ed. Philadelphia: WB Saunders, 2000: 1731-1773.
  • 9Stehouwer C D, Lambert J, Donker A J, et al. Endothelial dysfunction and pathogenesis of diabetic angiopathy[J]. Cardiovascular Research, 1997, 34(1) :55-68.
  • 10Hargrove G M, Dufresne J, Whiteside C. Diabetes mellitus increases endothelin- 1 gene transcription in rat kidney [ J ]. Kidney hat, 2000, 58(4) : 1534-1545.

共引文献62

同被引文献22

二级引证文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部